Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
4,250,301
-
Share change
-
+4,197,999
-
Total reported value
-
$185,367,037
-
Price per share
-
$43.53
-
Number of holders
-
67
-
Value change
-
+$183,087,502
-
Number of buys
-
62
-
Number of sells
-
1
Institutional Holders of GSK plc - SPONSORED ADR (GSK) as of Q2 2022
As of 30 Jun 2022,
GSK plc - SPONSORED ADR (GSK) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,250,301 shares.
The largest 10 holders included
CAPTRUST FINANCIAL ADVISORS, KORNITZER CAPITAL MANAGEMENT INC /KS, VAN ECK ASSOCIATES CORP, MARSHALL WACE, LLP, CAUSEWAY CAPITAL MANAGEMENT LLC, KEATING INVESTMENT COUNSELORS INC, OAK ASSOCIATES LTD /OH/, Edge Capital Group, LLC, MERITAGE PORTFOLIO MANAGEMENT, and ZEVIN ASSET MANAGEMENT LLC.
This page lists
67
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.